About this trial
Eustachian tube dysfunction is distressing probelm. drugs usually are not effective. compelemtary tehrapies like Buteyko breathing may be effective
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Eustachian Tube Dysfunction (chronic obstructive form)
unilateral ear affetion
senior patients
chronci affection more than 3 months
Disqualifiers
obesity
cardiac probelms repsiratory problems
Trial design
Parallel
Treatments tested in this trial
Buteyko breathing
Other interventiontwenty seniors with Eustachian tube dysfunction (chronic obstructive form) will be ranomized to group I and this group will take usual care (budesonide spray in nose in 64 microgram concentration one time per day plus the intake of a tablet two times daily containing containing 20-mg contration of pseudoephedrine hydrochloride and 5-mg concentration of loratadine) for 2 weeks. Also, group I will aslo receive 30-min Buteyko breathing two times daily for 14 weeks.
usual care
Other interventiontwenty seniors with Eustachian tube dysfunction (chronic obstructive form) will be ranomized to group II and this group will take usual care (budesonide spray in nose in 64 microgram concentration one time per day plus the intake of a tablet two times daily containing containing 20-mg contration of pseudoephedrine hydrochloride and 5-mg concentration of loratadine) for 2 weeks.
Treatment groups
Trial outcomes
Primary outcomes
Eustachian Tube Dysfunction Questionnaire
it will be used to asses symptoms of Eustachian Tube Dysfunction
Secondary outcomes
systolic blood pressure
it will be measured manually by manual sphygmomanometer
diastolic blood pressure
it will be measured manually by manual sphygmomanometer
respiratory rate
it will assess breath number per minute
pulse rate
it will assess pulse number per minute from radial artery
Sponsors and contacts
Click on the lead sponsor to view all of their trials.